Clinical trial
Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer
NCT00020046
Study timeline
Study start (unknown)1999-12-01Date precision: month
Registry last updated2023-10-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Stage IV Prostate Cancerunresolved
Adenocarcinoma of the Prostateunresolved
Recurrent Prostate Cancerunresolved
Interventions
docetaxelDRUG · verified · RxNorm: docetaxel
thalidomideDRUG · verified · RxNorm: thalidomide
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00020046 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.